MANCARDI, GIOVANNI LUIGI
 Distribuzione geografica
Continente #
EU - Europa 54.761
AS - Asia 5.015
NA - Nord America 3.787
SA - Sud America 485
AF - Africa 97
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 64.150
Nazione #
IT - Italia 53.962
US - Stati Uniti d'America 3.532
SG - Singapore 2.219
CN - Cina 1.255
VN - Vietnam 762
FR - Francia 407
BR - Brasile 288
BD - Bangladesh 275
HK - Hong Kong 165
DE - Germania 92
CA - Canada 88
AR - Argentina 79
FI - Finlandia 59
JP - Giappone 51
MX - Messico 50
IN - India 40
IQ - Iraq 39
CH - Svizzera 38
ID - Indonesia 36
GB - Regno Unito 35
CO - Colombia 31
EC - Ecuador 31
NL - Olanda 25
ES - Italia 23
JM - Giamaica 22
ZA - Sudafrica 19
CR - Costa Rica 18
CL - Cile 17
UA - Ucraina 17
TR - Turchia 16
TH - Thailandia 15
SA - Arabia Saudita 14
IE - Irlanda 13
PK - Pakistan 13
VE - Venezuela 13
PH - Filippine 12
RU - Federazione Russa 12
GT - Guatemala 11
HN - Honduras 11
KE - Kenya 11
MA - Marocco 11
NI - Nicaragua 11
TN - Tunisia 11
TW - Taiwan 11
DZ - Algeria 10
JO - Giordania 9
PR - Porto Rico 9
TT - Trinidad e Tobago 9
UZ - Uzbekistan 9
HR - Croazia 8
PL - Polonia 8
PY - Paraguay 8
SE - Svezia 8
EG - Egitto 7
KR - Corea 7
LT - Lituania 7
MY - Malesia 7
PE - Perù 7
AZ - Azerbaigian 6
BB - Barbados 6
BO - Bolivia 6
IL - Israele 6
LB - Libano 6
NP - Nepal 6
SC - Seychelles 6
SV - El Salvador 6
AT - Austria 5
BE - Belgio 5
KG - Kirghizistan 5
PS - Palestinian Territory 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
KZ - Kazakistan 4
MN - Mongolia 4
RS - Serbia 4
SN - Senegal 4
AL - Albania 3
GH - Ghana 3
PA - Panama 3
RO - Romania 3
AU - Australia 2
BS - Bahamas 2
BY - Bielorussia 2
BZ - Belize 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
HT - Haiti 2
LK - Sri Lanka 2
MU - Mauritius 2
OM - Oman 2
PT - Portogallo 2
QA - Qatar 2
SI - Slovenia 2
SO - Somalia 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AM - Armenia 1
Totale 64.119
Città #
Genova 35.457
Genoa 11.096
Rapallo 4.076
Vado Ligure 2.943
Singapore 1.065
San Jose 1.064
Lauterbourg 377
Ashburn 351
Ho Chi Minh City 222
Beijing 200
Hanoi 174
New York 162
Hong Kong 152
Santa Clara 98
Bordighera 80
Frankfurt am Main 74
Los Angeles 63
Helsinki 59
Rome 43
Tokyo 42
Chicago 38
Council Bluffs 37
Da Nang 35
Haiphong 35
Zurich 35
Mexico City 33
São Paulo 33
Dallas 32
Buffalo 31
Atlanta 30
Orem 26
Phoenix 26
Tianjin 26
Brooklyn 22
Houston 22
Milan 22
Washington 21
Detroit 17
Kingston 17
Amsterdam 16
Naples 16
Biên Hòa 15
San José 15
Montreal 14
Queens 14
Shanghai 14
Johannesburg 13
Las Vegas 13
Baghdad 12
Newark 12
Toronto 12
Charlotte 11
Des Moines 11
Dublin 11
Philadelphia 11
Princeton 11
Bar Harbor 10
Managua 10
Nuremberg 10
Can Tho 9
Denver 9
Guatemala City 9
Hải Dương 9
Madrid 9
Nairobi 9
Paris 9
San Antonio 9
San Francisco 9
Santiago 9
Walled Lake 9
Amman 8
Bogotá 8
Calgary 8
Chennai 8
City of London 8
Guayaquil 8
Manchester 8
Phủ Lý 8
Tampa 8
Tashkent 8
Warsaw 8
Caracas 7
Catania 7
Cincinnati 7
Curitiba 7
Dhaka 7
Guangzhou 7
Louisville 7
Memphis 7
Ninh Bình 7
Orlando 7
Padua 7
Quito 7
Thái Nguyên 7
Turin 7
Baku 6
Bari 6
Bologna 6
Buenos Aires 6
Cardiff 6
Totale 58.902
Nome #
An updated Italian normative dataset for the Stroop color word test (SCWT) 277
Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS 270
Finger motor performance as a new quantitative clinical endpoint in multiple sclerosis 247
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. 246
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy 244
17p11.2 duplication is a common finding in sporadic cases of charcot-marie-tooth type 1 242
Dysimmune mononeuropathies: A diagnosis not to be missed 239
A normative study of the Italian printed word version of the free and cued selective reminding test 234
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. 234
Cord cross-sectional area at foramen magnum as a correlate of disability in amyotrophic lateral sclerosis 231
Neural correlates of ankle movements during different motor tasks: A feasibility study 225
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis 224
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. 224
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. 222
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 220
Clinical epidemiology of ALS in Liguria, Italy. 219
Association of melanoma and natalizumab therapy in the Italian MS population: a second case report. 218
Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption 215
Acute axonal form of Guillain-Barre syndrome in a multiple sclerosis patient: chance association or linked disorders? 211
Basal ganglia are active during motor performance recovery after a demanding motor task. 208
A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients. 208
Neural correlates of lower limbs proprioception: An fMRI study of foot position matching 208
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. 207
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 207
Different MRI patterns in MS worsening after stopping fingolimod 207
Granulocyte-macrophage colony-stimulating factor activity in cerebrospinal fluid 206
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. 206
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register 206
Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine 205
Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. 204
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 204
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. 204
An engineered glove for investigating the neural correlates of finger movements using functional magnetic resonance imaging 204
Fast course ALS presenting with vocal cord paralysis: clinical features, bioinformatic and modelling analysis of the novel SOD1 Gly147Ser mutation. 203
Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study 198
Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers. 196
Hereditary motor and sensory neuropathy with myelin outfolding: clinical, genetic and neuropathological study of three cases 196
A New App for At-Home Cognitive Training: Description and Pilot Testing on Patients with Multiple Sclerosis 196
Evidence for aerobic ATP synthesis in isolated myelin vesicles 195
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. 195
Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. 195
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis. 194
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry. 193
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 193
The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse. 193
Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017 193
Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families. 191
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease 191
Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. 190
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. 190
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. 189
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. 189
Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1 188
Analisi e studio longitudinale della fine specificità di linee linfocitarie T specifiche per la proteina basica della mielina (MBP) in pazienti con sclerosi multipla e in controlli normali. 187
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 187
Delirium in the acute phase after stroke: comparison between methods of detection 187
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations 186
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results. 186
Impairment in explicit visuomotor sequence learning is related to loss of microstructural integrity of the corpus callosum in multiple sclerosis patients with minimal disability. 185
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 185
Direct immunofluorescence in sural nerve biopsies. 184
Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks 183
A patient with multiple sclerosis and Down's syndrome with a rare paroxysmal symptom at onset. 183
National Institutes of Health Stroke Scale in patients with primary intracerebral hemorrhage 183
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 183
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 182
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. 182
Demyelination and axonal damage in a non-human primate model of multiple sclerosis. 181
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases 180
Gain of glycosylation: a new pathomechanism of Myelin Protein Zero mutations 180
Teriflunomide treatment reduces B cells in patients with MS. 180
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. 179
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study. 179
Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis 179
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies 178
A prospective study of acute idiopathic neuropathy II antecedent events. 178
GFAP expression of human Schwann cells in tissue culture. 178
Screening, diagnosis, and management of obstructive sleep apnea in dangerous-goods truck drivers: to be aware or not? 178
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. 177
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal. 177
OXCARBAZEPINE FOR TREATING PAROXYSMAL PAINFUL SYMPTOMS IN MULTIPLE SCLEROSIS: A PILOT STUDY. 176
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. 176
Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter? 176
Early electophysiological changes in transgenic rat model of charcot-marie-tooth. 175
An Italian family with Ala-47 transthyretin mutation associated with cardiomyopathy and polyneuropathy. 175
Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease. 175
Cingulum bundle alterations underlie subjective fatigue in multiple sclerosis 175
[Hereditary sensory motor neuropathy: degenerative disease or a disease with an immune-mediated pathogenesis?]. 175
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial. 175
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis. 174
Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy 174
CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MS 174
Accumulation of clonally-related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients 173
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod 173
Central and peripheral nervous system complications following allogeneic bone marrow transplantation. 173
Retinal nerve fibre layer measurements and optic nerve head analysis in multiple sclerosis patients. 172
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 172
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 172
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis. 171
Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience. 171
Totale 19.578
Categoria #
all - tutte 197.202
article - articoli 179.865
book - libri 904
conference - conferenze 15.008
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.425
Totale 394.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.493 165 399 656 695 170 292 287 1.250 217 494 152 716
2022/20234.881 491 396 58 467 803 858 20 370 854 27 467 70
2023/20242.539 154 340 64 283 190 521 201 152 131 35 122 346
2024/20257.294 248 564 249 465 989 778 631 1.134 324 335 627 950
2025/202612.726 1.593 388 745 1.100 1.688 1.292 2.079 582 799 1.171 565 724
2026/20271.287 1.287 0 0 0 0 0 0 0 0 0 0 0
Totale 64.720